Form 4 for DGX Quest Diagnostics
Accepted 2024-05-20 00:00:00 ET · period of report 2024-05-16 · accession 0001022079-24-000119 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-20 | 2024-05-16 | DGX | Lassiter Wright III | Dir | A - Grant | $0.00 | +1,482 | 7,709 | +24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-16 | A | A | 1,482 | $0.00 | 7,709 | D | — | — | (F1) Represents an award of restricted share units. (F2) The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. |